Martin et al. also demonstrated significantly higher levels of GM-CSF in the cerebrospinal fluid of MS patients, suggesting that elevated GM-CSF levels may reflect intrathecal production of this cytokine [45]. The gene discussed is CSF2; the disease is myeloid sarcoma.